Emergent BioSolutions Inc.
US ˙ NYSE ˙ US29089Q1058

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Adam Havey. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Adam Havey har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:EBS / Emergent BioSolutions Inc. EVP, Business Operations 174.398
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Adam Havey. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb EBS / Emergent BioSolutions Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i EBS / Emergent BioSolutions Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2015-06-01 EBS Havey Adam 98 27,0800 98 27,0800 2.654 365 41.1071 1.375 51,85

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EBS / Emergent BioSolutions Inc. Insider Trades
Insidersalg EBS / Emergent BioSolutions Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i EBS / Emergent BioSolutions Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2014-03-12 EBS Havey Adam 11.562 27,5000 11.562 27,5000 317.955 216 18.6612 -102.194 -32,14
2014-03-11 EBS Havey Adam 5.835 26,9600 5.835 26,9600 157.312
2014-03-11 EBS Havey Adam 11.820 26,9600 11.820 26,9600 318.667

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EBS / Emergent BioSolutions Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Adam Havey som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-06-13 2023-06-09 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 49.231 174.398 39,33
2023-06-13 2023-06-09 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 24.616 125.167 24,48
2023-03-06 2023-03-02 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 12.308 100.551 13,95
2023-03-06 2023-03-02 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 6.154 88.243 7,50
2023-03-02 2023-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -998 33.927 -2,86 12,38 -12.355 420.016
2023-02-27 2023-02-24 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -812 33.681 -2,35 13,71 -11.133 461.767
2023-02-27 2023-02-23 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -432 34.493 -1,24 14,30 -6.178 493.250
2023-02-10 2023-02-08 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.964 34.925 -5,32 13,25 -26.023 462.756
2023-02-10 2023-02-08 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 95 36.889 0,26
2022-03-02 2022-03-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
A - Award 42.289 42.289 41,38 1.749.919 1.749.919
2022-03-02 2022-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 17.822 86.939 25,79
2022-03-02 2022-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 32.323 69.117 87,85
2022-03-02 2022-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -739 86.200 -0,85 39,64 -29.294 3.416.968
2022-02-25 2022-02-24 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -828 36.794 -2,20 42,47 -35.165 1.562.641
2022-02-25 2022-02-23 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -424 37.622 -1,11 42,23 -17.906 1.588.777
2022-02-24 2022-02-22 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.980 38.046 -4,95 42,23 -83.615 1.606.683
2022-02-24 2022-02-22 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 1.836 40.026 4,81
2021-03-03 2021-03-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -20.145 0 -100,00 99,02 -1.994.758
2021-03-03 2021-03-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -17.134 0 -100,00 99,62 -1.706.889
2021-03-03 2021-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.145 38.190 -34,53 99,02 -1.994.758 3.781.574
2021-03-03 2021-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.145 58.335 52,75 49,64 999.998 2.895.749
2021-03-03 2021-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -17.134 38.190 -30,97 99,62 -1.706.889 3.804.488
2021-03-03 2021-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 17.134 55.324 44,87 30,63 524.814 1.694.574
2021-02-26 2021-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -732 38.190 -1,88 97,15 -71.114 3.710.158
2021-02-26 2021-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -739 38.922 -1,86 97,15 -71.794 3.781.272
2021-02-26 2021-02-24 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
A - Award 14.973 14.973 93,49 1.399.826 1.399.826
2021-02-26 2021-02-24 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -847 39.661 -2,09 93,49 -79.186 3.707.907
2021-02-26 2021-02-24 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 3.744 40.508 10,18
2021-02-26 2021-02-24 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 3.744 40.508 10,18
2021-02-11 2021-02-09 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.183 33.020 -6,20 123,45 -269.491 4.076.319
2021-02-11 2021-02-09 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 2.518 35.203 7,70
2020-04-21 2020-04-20 4 EBS Emergent BioSolutions Inc.
Stock Options (Right to Buy)
S - Sale X -17.009 80.384 -17,46
2020-04-21 2020-04-20 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -17.009 34.256 -33,18 69,00 -1.173.621 2.363.664
2020-04-21 2020-04-20 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 17.009 51.265 49,65 30,86 524.898 1.582.038
2020-04-21 2020-04-17 4 EBS Emergent BioSolutions Inc.
Stock Options (Right to Buy)
S - Sale X -20.414 97.393 -17,33
2020-04-21 2020-04-17 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.414 34.256 -37,34 65,00 -1.326.910 2.226.640
2020-04-21 2020-04-17 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.414 54.670 59,59 26,45 539.950 1.446.022
2020-04-08 2020-04-06 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -3.730 34.256 -9,82 60,00 -223.800 2.055.360
2020-04-08 2020-04-06 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -4.242 37.986 -10,05 60,00 -254.520 2.279.160
2020-02-27 2020-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -409 42.228 -0,96 58,42 -23.894 2.466.960
2020-02-27 2020-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -484 42.637 -1,12 59,91 -28.996 2.554.383
2020-02-27 2020-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -513 43.121 -1,18 59,91 -30.734 2.583.379
2020-02-27 2020-02-25 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
A - Award 22.784 43.105 112,12 61,44 1.399.849 2.648.371
2020-02-27 2020-02-25 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.697 43.634 15,02
2020-02-27 2020-02-25 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.697 43.634 15,02
2019-03-13 2019-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -2.430 32.240 -7,01 56,93 -138.340 1.835.423
2019-03-04 2019-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -2.024 34.670 -5,52 58,20 -117.797 2.017.794
2019-03-04 2019-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -1.019 36.694 -2,70 57,92 -59.022 2.125.383
2019-02-28 2019-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -812 37.713 -2,11 58,71 -47.673 2.214.130
2019-02-28 2019-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -409 38.525 -1,05 57,98 -23.714 2.233.680
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to Buy)
A - Award 20.321 20.321 61,01 1.239.784 1.239.784
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.081 38.934 15,01
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.081 33.853 17,66
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -481 28.772 -1,64 61,01 -29.346 1.755.380
2018-11-05 2018-11-02 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise X 6.168 0 -100,00
2018-11-05 2018-11-02 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -6.168 29.253 -17,41 64,50 -397.836 1.886.818
2018-11-05 2018-11-02 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 6.168 35.421 21,09 25,62 158.024 907.486
2018-11-05 2018-11-01 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise X 2.011 6.168 48,38
2018-11-05 2018-11-01 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -2.011 29.253 -6,43 63,50 -127.698 1.857.566
2018-11-05 2018-11-01 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 2.011 31.264 6,87 25,62 51.522 800.984
2018-10-24 2018-10-17 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -314 29.253 -1,06 63,50 -19.939 1.857.566
2018-10-19 2018-10-17 4 EBS Emergent BioSolutions Inc.
Stock Options (Right to Buy)
M - Exercise X -314 8.179 -3,70
2018-10-19 2018-10-17 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -314 29.253 -1,06 61,50 -19.311 1.799.060
2018-10-19 2018-10-17 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 314 29.567 1,07 25,62 8.045 757.507
2018-10-17 2018-10-16 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise X -3.840 8.493 -31,14
2018-10-17 2018-10-16 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise X -6.165 12.333 -33,33
2018-10-17 2018-10-16 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -3.840 29.253 -11,60 63,50 -243.840 1.857.566
2018-10-17 2018-10-16 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 3.840 33.093 13,13 25,62 98.381 847.843
2018-10-17 2018-10-16 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -6.165 29.253 -17,41 61,50 -379.148 1.799.060
2018-10-17 2018-10-16 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 6.165 35.418 21,07 25,62 157.947 907.409
2018-10-17 2018-10-15 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise X -6.165 18.498 -25,00
2018-10-17 2018-10-15 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise X -6.165 18.498 -25,00
2018-10-17 2018-10-15 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -661 29.253 -2,21 60,67 -40.103 1.774.780
2018-10-17 2018-10-15 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -6.165 29.914 -17,09 60,03 -370.081 1.795.716
2018-10-17 2018-10-15 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 6.165 36.079 20,61 25,62 157.947 924.344
2018-10-17 2018-10-15 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 6.165 36.079 20,61 25,62 157.947 924.344
2018-10-17 2018-10-15 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -6.165 29.914 -17,09 60,15 -370.855 1.799.474
2018-03-13 2018-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -5.842 29.914 -16,34 52,82 -308.574 1.580.057
2018-03-13 2018-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -974 35.756 -2,65 51,84 -50.492 1.853.591
2018-03-09 2018-03-07 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise -6.573 0 -100,00
2018-03-09 2018-03-07 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.843 36.730 -7,18 50,43 -143.372 1.852.294
2018-03-09 2018-03-07 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 6.573 39.573 19,92 22,03 144.803 871.793
2018-03-01 2018-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -1.898 33.000 -5,44 49,50 -93.951 1.633.500
2018-03-01 2018-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -811 34.898 -2,27 49,97 -40.526 1.743.853
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy
A - Award 20.145 20.145 49,64 999.998 999.998
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -409 35.709 -1,13 49,64 -20.303 1.772.595
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.036 36.118 16,20
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5.036 36.118 16,20
2017-09-29 2017-09-27 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise -7.885 0 -100,00
2017-09-29 2017-09-27 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -7.885 26.046 -23,24 39,50 -311.458 1.028.817
2017-09-29 2017-09-27 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 7.885 33.931 30,27 22,03 173.707 747.500
2017-09-12 2017-09-08 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise -7.885 7.885 -50,00
2017-09-12 2017-09-08 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -7.885 26.046 -23,24 37,06 -292.243 965.346
2017-09-12 2017-09-08 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 7.885 33.931 30,27 22,03 173.707 747.500
2017-04-04 2017-04-03 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -11.419 26.046 -30,48 28,62 -326.808 745.429
2017-03-16 2017-03-15 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift -1.800 37.465 -4,58
2017-03-10 2017-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.624 39.265 -3,97 31,05 -50.425 1.219.178
2017-03-10 2017-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.076 40.889 -2,56 30,98 -33.334 1.266.741
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy
A - Award 17.134 17.134 30,63 524.814 524.814
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -938 41.965 -2,19 30,63 -28.731 1.285.388
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 4.285 42.903 11,10
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 4.285 42.903 11,10
2017-01-19 2017-01-17 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -8.438 34.333 -19,73 29,75 -251.001 1.021.287
2017-01-19 2016-08-01 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to buy)
J - Other 1.495 17.009 9,64
2017-01-19 2016-08-01 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to buy)
J - Other 1.794 20.414 9,63
2017-01-19 2016-08-01 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to buy)
J - Other 2.709 30.828 9,63
2017-01-19 2016-08-01 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to buy)
J - Other 1.386 15.770 9,64
2017-01-19 2016-08-01 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to buy)
J - Other 577 6.573 9,62
2017-01-19 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 748 42.771 1,78
2017-01-19 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 599 42.023 1,45
2017-01-19 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 452 41.424 1,10
2016-03-31 2016-03-30 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 3.467 0 -100,00
2016-03-31 2016-03-30 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 3.467 40.972 9,24 15,91 55.160 651.865
2016-03-16 2016-03-14 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -1.658 37.505 -4,23 33,96 -56.306 1.273.670
2016-03-16 2016-03-14 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -2.701 39.163 -6,45 33,96 -91.726 1.329.975
2016-03-15 2016-03-11 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 7.960 0 -100,00
2016-03-15 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.278 41.864 -2,96 34,22 -43.733 1.432.586
2016-03-15 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -3.152 43.142 -6,81 33,84 -106.664 1.459.925
2016-03-15 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -7.960 46.294 -14,67 33,84 -269.366 1.566.589
2016-03-15 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7.960 54.254 17,19 14,67 116.773 795.906
2016-03-11 2016-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.480 46.294 -3,10 34,38 -50.882 1.591.588
2016-03-11 2016-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.061 47.774 -2,17 34,60 -36.711 1.652.980
2016-03-03 2016-03-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
A - Award 15.514 15.514
2016-03-03 2016-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 7.759 48.835 18,89
2015-06-26 2015-06-24 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 10.238 0 -100,00
2015-06-26 2015-06-24 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 10.238 41.076 33,20 18,90 193.498 776.336
2015-06-17 2015-06-15 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -9.773 0 -100,00
2015-06-17 2015-06-15 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -15.919 7.960 -66,67
2015-06-17 2015-06-15 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -10.606 30.838 -25,59 31,50 -334.110 971.459
2015-06-17 2015-06-15 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -9.773 41.444 -19,08 31,66 -309.462 1.312.324
2015-06-17 2015-06-15 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9.773 51.217 23,58 15,83 154.707 810.765
2015-06-17 2015-06-15 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -15.919 41.444 -27,75 31,50 -501.480 1.305.569
2015-06-17 2015-06-15 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 15.919 57.363 38,41 14,67 233.532 841.515
2015-06-02 2015-06-01 4 EBS Emergent BioSolutions Inc.
Common Stock
P - Purchase 98 41.444 0,24 27,08 2.654 1.122.304
2015-03-12 2015-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -785 41.073 -1,88 28,67 -22.506 1.177.563
2015-03-12 2015-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.278 41.858 -2,96 28,99 -37.049 1.213.463
2015-03-12 2015-03-10 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
A - Award 18.620 18.620
2015-03-12 2015-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.535 43.136 -3,44 29,00 -44.515 1.250.944
2015-03-12 2015-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 9.313 44.671 26,34
2014-10-16 2014-05-31 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 290 35.358 0,83 18,44 5.348 652.002
2014-03-18 2014-03-14 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.077 35.068 -2,98 27,06 -29.144 948.940
2014-03-13 2014-03-12 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
M - Exercise -11.562 0 -100,00
2014-03-13 2014-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -11.562 36.145 -24,24 27,50 -317.955 993.988
2014-03-13 2014-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 11.562 47.707 31,99 18,90 218.522 901.662
2014-03-13 2014-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -775 36.145 -2,10 27,15 -21.041 981.337
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
M - Exercise -4.887 4.887 -50,00
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
M - Exercise -6.933 0 -100,00
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
A - Award 28.119 28.119
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -11.820 36.920 -24,25 26,96 -318.667 995.363
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 6.933 48.800 16,56 15,91 110.304 776.408
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 4.887 41.807 13,24 15,83 77.361 661.805
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -5.835 36.920 -13,65 26,96 -157.312 995.363
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 14.060 42.755 49,00
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.336 28.695 -4,45 28,09 -37.528 806.043
2013-03-18 2013-03-14 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.046 36.823 -2,76 14,46 -15.125 532.461
2013-03-12 2013-03-12 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
A - Award 23.879 23.879
2013-03-12 2013-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 11.939 31.077 62,38
2013-03-12 2013-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -820 19.138 -4,11 14,67 -12.029 280.754
2013-03-12 2013-03-08 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -642 19.958 -3,12 15,22 -9.771 303.761
2012-03-16 2012-03-14 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.049 27.970 -3,61 16,05 -16.836 448.918
2012-03-16 2012-03-13 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
A - Award 14.700 14.700
2012-03-16 2012-03-13 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 7.350 29.019 33,92
2012-03-12 2012-03-08 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -535 14.319 -3,60 14,49 -7.752 207.482
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)